NGB and glaucoma: Although neuroprotective therapies are not currently available for glaucoma patients, the findings of our study in a higher-order animal model, together with previous reports of rodent studies showing similar effects of Ngb in EG, may pave the way for the development of Ngb as a potential neuroprotective therapeutic agent in clinical glaucoma.